Company registration number 08059024 (England and Wales)
CLINICALL HEALTHCARE LTD
TRADING AS CLINICALL CIC
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023
PAGES FOR FILING WITH REGISTRAR
CLINICALL HEALTHCARE LTD
TRADING AS CLINICALL CIC
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
CLINICALL HEALTHCARE LTD
TRADING AS CLINICALL CIC
BALANCE SHEET
AS AT
31 MAY 2023
31 May 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
4,444
5,229
Current assets
Debtors
4
-
0
704
Cash at bank and in hand
1,111
1,626
1,111
2,330
Creditors: amounts falling due within one year
5
(118,215)
(113,632)
Net current liabilities
(117,104)
(111,302)
Net liabilities
(112,660)
(106,073)
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
(112,760)
(106,173)
Total equity
(112,660)
(106,073)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 20 February 2024 and are signed on its behalf by:
Mr S Khan
Director
Company registration number 08059024 (England and Wales)
CLINICALL HEALTHCARE LTD
TRADING AS CLINICALL CIC
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023
- 2 -
1
Accounting policies
Company information

Clinicall Healthcare Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit 402, Daisyfield Business Centre, Appleby Street, Blackburn, Lancashire, BB1 3BL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The company is reliant upon the financial support of its directorstrue and a connected company in order to meet its liabilities as they fall due. The director has indicated that this support will continue for the foreseeable future and, as a result, has continued to adopt the going concern basis in preparing the financial statements.

1.3
Turnover

Turnover represents amounts receivable for services provided.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
15% Reducing Balance
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

CLINICALL HEALTHCARE LTD
TRADING AS CLINICALL CIC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2023
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and other loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.10
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
3
3
CLINICALL HEALTHCARE LTD
TRADING AS CLINICALL CIC
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2023
- 4 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 June 2022 and 31 May 2023
17,822
Depreciation and impairment
At 1 June 2022
12,593
Depreciation charged in the year
785
At 31 May 2023
13,378
Carrying amount
At 31 May 2023
4,444
At 31 May 2022
5,229
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
-
0
704
5
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
936
1,286
Other creditors
117,279
112,346
118,215
113,632

Other creditors include £63,662 (2022 - £63,662) due to the directors and £52,896 (2022 - £48,044) due to a company under common control.

6
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
2023-05-312022-06-01false20 February 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityMr S KhanMr F K JanjuaBeardwood Asset Management Limitedfalse080590242022-06-012023-05-31080590242023-05-31080590242022-05-3108059024core:OtherPropertyPlantEquipment2023-05-3108059024core:OtherPropertyPlantEquipment2022-05-3108059024core:CurrentFinancialInstrumentscore:WithinOneYear2023-05-3108059024core:CurrentFinancialInstrumentscore:WithinOneYear2022-05-3108059024core:CurrentFinancialInstruments2023-05-3108059024core:CurrentFinancialInstruments2022-05-3108059024core:ShareCapital2023-05-3108059024core:ShareCapital2022-05-3108059024core:RetainedEarningsAccumulatedLosses2023-05-3108059024core:RetainedEarningsAccumulatedLosses2022-05-3108059024bus:Director12022-06-012023-05-3108059024core:FurnitureFittings2022-06-012023-05-31080590242021-06-012022-05-3108059024core:OtherPropertyPlantEquipment2022-05-3108059024core:OtherPropertyPlantEquipment2022-06-012023-05-3108059024bus:PrivateLimitedCompanyLtd2022-06-012023-05-3108059024bus:SmallCompaniesRegimeForAccounts2022-06-012023-05-3108059024bus:FRS1022022-06-012023-05-3108059024bus:AuditExemptWithAccountantsReport2022-06-012023-05-3108059024bus:Director22022-06-012023-05-3108059024bus:Director32022-06-012023-05-3108059024bus:FullAccounts2022-06-012023-05-31xbrli:purexbrli:sharesiso4217:GBP